SEARCH

SEARCH BY CITATION

References

  • 1
    Wagener MM, Yu VL. Bacteremia in transplant recipients: A prospective study of demographics, etiologic agents, risk factors, and outcomes. Am J Infect Control 1992; 20: 239247.
  • 2
    Alangaden GJ, Thyagarajan R, Gruber SA et al. Infectious complications after kidney transplantation: Current epidemiology and associated risk factors. Clin Transplant 2006; 20: 401409.
  • 3
    Fischer SA. Infections complicating solid organ transplantation. Surg Clin North Am 2006; 86: 11271145, v–vi.
  • 4
    Grimaldi A, Barletta A, Rascente M et al. Infectious complications in the renal transplant recipient. Transplant Proc 2005; 37: 25022503.
  • 5
    Kusne S, Dummer JS, Singh N et al. Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) 1988; 67: 132143.
  • 6
    Miemois-Foley J, Paunio M, Lyytikainen O, Salmela K. Bacteremia among kidney transplant recipients: A case-control study of risk factors and short-term outcomes. Scand J Infect Dis 2000; 32: 6973.
  • 7
    Patel R, Paya CV. Infections in solid-organ transplant recipients. Clin Microbiol Rev 1997; 10: 86124.
  • 8
    Husain S, Chan KM, Palmer SM et al. Bacteremia in lung transplant recipients in the current era. Am J Transplant 2006; 6: 30003007.
  • 9
    Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118: 146155.
  • 10
    Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 1999; 115: 462474.
  • 11
    Luna CM, Vujacich P, Niederman MS et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111: 676685.
  • 12
    Rello J, Gallego M, Mariscal D, Sonora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156: 196200.
  • 13
    Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244: 379386.
  • 14
    Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002; 122: 262268.
  • 15
    Luna CM, Aruj P, Niederman MS et al. Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Respir J 2006; 27: 158164.
  • 16
    Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36: 14181423.
  • 17
    Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004; 164: 637644.
  • 18
    Garner J, Hughes JM, Horan TC, Mori TG, Arvis WR. CDC definitions for nosocomial infections. In: OlmstedR, ed. APIC Infection Control and Applied Epidemiology: Principles and Practice, St. Louis , CO : Mosby, 1996: A1A20.
  • 19
    Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI document M100-S17, 2002.
  • 20
    NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32: 470485.
  • 21
    Gilbert DN, Moellering R Jr., Sande M. The Sanford Guide to Antimicrobial Therapy 2006. Hyde Park , VT : Antimicrobial Therapy Inc., 2006.
  • 22
    Hosmer D, Lemeshow S. Applied Logistic Regression. 2nd Ed. Toronto : Wiley, 2000.
  • 23
    Babyak MA. What you see may not be what you get: A brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 2004; 66: 411421.
  • 24
    Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996; 49: 13731379.
  • 25
    Canadian Organ Replacement Register C. e-Statistics on Organ Transplants, Waiting Lists and Donors; Table 1A. Transplants by Organ and Donor Type, Canada and Provinces, Summary Statistics, January 1 to December 31, 2003, 2004.
  • 26
    Micek ST, Lloyd AE, Ritchie DJ, Reichley RM, Fraser VJ, Kollef MH. Pseudomonas aeruginosa bloodstream infection: Importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother 2005; 49: 13061311.
  • 27
    Rello J, Ausina V, Ricart M, Castella J, Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993; 104: 12301235.
  • 28
    Kollef MH, Ward S, Sherman G et al. Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices. Crit Care Med 2000; 28: 34563464.
  • 29
    Vanderkooi OG, Low DE, Green K, Powis JE, McGeer A. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 2005; 40: 12881297.
  • 30
    Goldmann DA, Weinstein RA, Wenzel RP et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996; 275: 234240.
  • 31
    Singh N. Impact of current transplantation practices on the changing epidemiology of infections in transplant recipients. Lancet Infect Dis 2003; 3: 156161.
  • 32
    Rubin RH, Schaffner A, Speich R. Introduction to the Immunocompromised Host Society consensus conference on epidemiology, prevention, diagnosis, and management of infections in solid-organ transplant patients. Clin Infect Dis 2001; 33(Suppl 1): S1S4.
  • 33
    Torre-Cisneros J, Herrero C, Canas E, Reguera JM, De La MM, Gomez-Bravo MA. High mortality related with Staphylococcus aureus bacteremia after liver transplantation. Eur J Clin Microbiol Infect Dis 2002; 21: 385388.
  • 34
    Sitges-Serra A, Lopez MJ, Girvent M, Almirall S, Sancho JJ. Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis. Br J Surg 2002; 89: 361367.
  • 35
    Barie PS, Christou NV, Dellinger EP, Rout WR, Stone HH, Waymack JP. Pathogenicity of the enterococcus in surgical infections. Ann Surg 1990; 212: 155159.
  • 36
    Trouillet JL, Chastre J, Vuagnat A et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157: 531539.
  • 37
    Kollef MH, Kollef KE. Antibiotic utilization and outcomes for patients with clinically suspected ventilator-associated pneumonia and negative quantitative BAL culture results. Chest 2005; 128: 27062713.
  • 38
    Rello J, Ollendorf DA, Oster G et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122: 21152121.
  • 39
    Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis 2003; 36: 14331437.
  • 40
    Chamot E, Boffi EA, Rohner P, Van Delden C. Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother 2003; 47: 27562764.
  • 41
    Dellit TH, Owens RC, McGowan JJ et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis: Off Pub Infect Dis Soc Am 2007; 44: 159177.
  • 42
    Shlaes DM, Gerding DN, John JF, Jr et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997; 25: 584599.
  • 43
    Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J. Variations in etiology of ventilator-associated pneumonia across four treatment sites: Implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999; 160: 608613.
  • 44
    Namias N, Samiian L, Nino D et al. Incidence and susceptibility of pathogenic bacteria vary between intensive care units within a single hospital: Implications for empiric antibiotic strategies. J Trauma 2000; 49: 638645.